Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Navoikova A"'
Autor:
D. O. Maksimov, D. A. Naumova, E. A. Astakhova, V. V. Artemev, S. A. Biryukov, I. S. Abramov, A. A. Navoikova, N. V. Rudev, S. G. Feoktistova, O. V. Glazova, O. N. Mityaeva, P. Yu. Volchkov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 2, Pp 215-228 (2024)
INTRODUCTION. The creation of synthetic adeno-associated virus (AAV) vectors during gene therapy development is a labour-intensive and expensive process. The optimal solution to minimise the time and costs associated with gene therapy development lie
Externí odkaz:
https://doaj.org/article/ca88668e6b554917a47143e75b0e751a
Autor:
Sofia Feoktistova, Marya Sayganova, Kseniya Trutneva, Olga Glazova, Artem S. Blagodatski, Liudmila Shevkova, Anna Navoikova, Yuriy Anisimov, Eugene Albert, Olga Mityaeva, Pavel Volchkov, Andrey Deviatkin
Publikováno v:
Viruses, Vol 16, Iss 4, p 568 (2024)
Influenza A viruses (IAVs) pose a serious threat to global health. On the one hand, these viruses cause seasonal flu outbreaks in humans. On the other hand, they are a zoonotic infection that has the potential to cause a pandemic. The most important
Externí odkaz:
https://doaj.org/article/b5a3d5d76886446b92c9eb38b9ad81ad
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ivan A Molodtsov, Evgenii Kegeles, Alexander N Mitin, Olga Mityaeva, Oksana E Musatova, Anna E Panova, Mikhail V Pashenkov, Iuliia O Peshkova, Almaqdad Alsalloum, Walaa Asaad, Anna S Budikhina, Alexander S Deryabin, Inna V Dolzhikova, Ioanna N Filimonova, Alexandra N Gracheva, Oxana I Ivanova, Anastasia Kizilova, Viktoria V Komogorova, Anastasia Komova, Natalia I Kompantseva, Ekaterina Kucheryavykh, Denis А Lagutkin, Yakov A Lomakin, Alexandra V Maleeva, Elena V Maryukhnich, Afraa Mohammad, Vladimir V Murugin, Nina E Murugina, Anna Navoikova, Margarita F Nikonova, Leyla A Ovchinnikova, Yana Panarina, Natalia V Pinegina, Daria M Potashnikova, Elizaveta V Romanova, Aleena A Saidova, Nawar Sakr, Anastasia G Samoilova, Yana Serdyuk, Naina T Shakirova, Nina I Sharova, Saveliy A Sheetikov, Anastasia F Shemetova, Liudmila V Shevkova, Alexander V Shpektor, Anna Trufanova, Anna V Tvorogova, Valeria M Ukrainskaya, Anatoliy S Vinokurov, Daria A Vorobyeva, Ksenia V Zornikova, Grigory A Efimov, Musa R Khaitov, Ilya A Kofiadi, Alexey A Komissarov, Denis Y Logunov, Nelli B Naigovzina, Yury P Rubtsov, Irina A Vasilyeva, Pavel Volchkov, Elena Vasilieva
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(1)
Background During the ongoing coronavirus disease 2019 (COVID-19) pandemic, many individuals were infected with and have cleared the virus, developing virus-specific antibodies and effector/memory T cells. An important unanswered question is what lev
Autor:
V. M. Ukrainskaya, Denis Y. Logunov, Alexandra V. Maleeva, O. Ivanova, Inna V. Dolzhikova, Grigory A. Efimov, Iuliia O. Peshkova, Leila Ovchinnikova, Elizaveta Romanova, Savely A. Sheetikov, Alexandra Gracheva, Ksenia V. Zornikova, Alexander Mitin, Ioanna N. Filimonova, Anna Tvorogova, Alexey A. Komissarov, Nelli B. Naigovzina, Anna Navoikova, Mikhail Pashenkov, Yakov A. Lomakin, Liudmila Shevkova, Aleksander Deryabin, Anna Panova, D. Vorobyeva, E. Maryukhnich, N. Pinegina, Yury P. Rubtsov, Denis Lagutkin, Musa Khaitov, Viktoria Komogorova, Yana Serdyuk, Oksana Musatova, Walaa Asaad, Irina Vasilyeva, Anastasia Samoilova, Vladimir Murugin, Afraa Mohammad, Pavel Volchkov, Anatoliy Vinokurov, Daria Potashnikova, Natalia Kompantseva, Ivan Molodtsov, Anastasia Kizilova, Evgenii Kegeles, Nawar Sakr, Anna Trufanova, Alexander Shpektor, Elena Vasilieva, Aleena Saidova, Olga Mityaeva, Nina Murugina, Naina T. Shakirova, Nina Sharova, Anastasia Komova, Ilya Kofiadi, Anastasia Shemetova, Anna Budikhina, Margarita Nikonova, Alsalloum Almaqdad
Background Coronavirus disease COVID-19 has spread worldwide extremely rapidly. Although many individuals have been infected and have cleared the virus, developing virus-specific antibodies and effector/memory T cells, an important question still to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ad609d16d6841d8058374892924746a
https://doi.org/10.1101/2021.08.19.21262278
https://doi.org/10.1101/2021.08.19.21262278